Jacqueline Zummo, Chief Scientific Operations Officer at Protara Therapeutics ($TARA), made one open market sale of company shares in the last 365 days, totaling $96,145. Her most recent sale occurred on March 26, 2025. These sales rank her 9,641st out of 11,678 insiders by amount sold, well below the average of 8.6 million across 6.4 transactions. Zummo Jacqueline reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chief R&D Officer | S | Common Stock | 22598 | $5.26 | 95,961.0000 | 42,836,129 | 19.06% | 0.05% |
| Jan. 26, 2026 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 3724 | $6.67 | 118,559.0000 | 42,272,104 | 3.05% | 0.01% |
| Jan. 20, 2026 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 6578 | $5.60 | 122,283.0000 | 42,272,104 | 5.10% | 0.02% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Common Stock | 30000 | $0.00 | 128,861.0000 | 42,272,104 | 30.35% | 0.07% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 42,272,104 | 9999.99% | 0.43% |
| March 26, 2025 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | S | Common Stock | 21224 | $4.53 | 98,861.0000 | 20,592,847 | 17.67% | 0.10% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Common Stock | 24500 | $0.00 | 126,639.0000 | 20,592,847 | 23.99% | 0.12% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Stock Option (Right to Buy) | 146000 | $0.00 | 146,000.0000 | 20,592,847 | 9999.99% | 0.71% |
| Jan. 21, 2025 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 6554 | $4.76 | 95,585.0000 | 20,592,847 | 6.42% | 0.03% |
| Jan. 3, 2025 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 2157 | $6.14 | 102,139.0000 | 20,592,847 | 2.07% | 0.01% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Common Stock | 23000 | $0.00 | 107,345.0000 | 11,331,338 | 27.27% | 0.20% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | A | Stock Option (Right to Buy) | 137000 | $0.00 | 137,000.0000 | 11,331,338 | 9999.99% | 1.21% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 3049 | $1.91 | 104,296.0000 | 11,331,338 | 2.84% | 0.03% |
| Jan. 10, 2024 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 5229 | $2.39 | 84,345.0000 | 11,331,338 | 5.84% | 0.05% |
| Jan. 3, 2024 | Protara Therapeutics, Inc. | $PRTO | Zummo Jacqueline | Chf Scientific Operations Off | F | Common Stock | 1899 | $2.17 | 89,574.0000 | 11,331,338 | 2.08% | 0.02% |